PT3016666T - Formulação de óleo marinho que compreende resveratrol ou derivados do mesmo para utilizar no tratamento, retardamento e/ou prevenção de doença de alzheimer - Google Patents
Formulação de óleo marinho que compreende resveratrol ou derivados do mesmo para utilizar no tratamento, retardamento e/ou prevenção de doença de alzheimerInfo
- Publication number
- PT3016666T PT3016666T PT14811285T PT14811285T PT3016666T PT 3016666 T PT3016666 T PT 3016666T PT 14811285 T PT14811285 T PT 14811285T PT 14811285 T PT14811285 T PT 14811285T PT 3016666 T PT3016666 T PT 3016666T
- Authority
- PT
- Portugal
- Prior art keywords
- reservatrol
- desease
- delaying
- derivatives
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361834455P | 2013-06-13 | 2013-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3016666T true PT3016666T (pt) | 2019-07-11 |
Family
ID=52022528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT14811285T PT3016666T (pt) | 2013-06-13 | 2014-06-13 | Formulação de óleo marinho que compreende resveratrol ou derivados do mesmo para utilizar no tratamento, retardamento e/ou prevenção de doença de alzheimer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9717704B2 (pt) |
| EP (1) | EP3016666B1 (pt) |
| JP (2) | JP6648007B2 (pt) |
| KR (1) | KR20160018801A (pt) |
| CN (1) | CN105283190A (pt) |
| AU (1) | AU2014278839B2 (pt) |
| CA (1) | CA2914767A1 (pt) |
| DK (1) | DK3016666T3 (pt) |
| ES (1) | ES2732307T3 (pt) |
| MX (1) | MX363853B (pt) |
| PL (1) | PL3016666T3 (pt) |
| PT (1) | PT3016666T (pt) |
| SI (1) | SI3016666T1 (pt) |
| WO (1) | WO2014200356A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014172363A2 (en) | 2013-04-19 | 2014-10-23 | The Board Of Trustees Of The University Of Arkansas | Combretastatin analogs |
| JP6648007B2 (ja) * | 2013-06-13 | 2020-02-14 | スマートフィッシュ・アーエス | アルツハイマー病の治療、遅延及び/又は予防において使用するための、レスベラトロール又はその誘導体を含む水産油配合物 |
| AU2014302589B2 (en) | 2013-06-24 | 2020-05-14 | Wilson Wolf Manufacturing, LLC | Closed system device and methods for gas permeable cell culture process |
| GB201405033D0 (en) | 2014-03-20 | 2014-05-07 | Isis Innovation | Combination therapy |
| EP3125886A4 (en) | 2014-03-31 | 2017-09-06 | Bioventures, Llc | Disubstituted triazole analogs |
| NO20160913A1 (en) * | 2016-05-27 | 2017-11-28 | Smartfish As | Use of a composition comprising marine oil and juice for improving muscle performance. |
| WO2018144910A1 (en) * | 2017-02-02 | 2018-08-09 | Bioventures, Llc | Methods of protecting against neurodegeneration |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897388A (en) * | 1988-12-20 | 1990-01-30 | Geriatric Research Institute, Inc. | Method of treating Alzheimer's disease |
| US6184248B1 (en) * | 1996-09-05 | 2001-02-06 | Robert K. K. Lee | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| NO313076B1 (no) * | 1999-12-28 | 2002-08-12 | Pronova Biocare As | Flytende n¶rings- og/eller nytelsesmiddel og fremgangsmåte for fremstilling derav |
| US6964969B2 (en) * | 2001-04-19 | 2005-11-15 | Mccleary Edward Larry | Composition and method for treating impaired or deteriorating neurological function |
| EP1633208A1 (en) * | 2003-05-27 | 2006-03-15 | DSM IP Assets B.V. | Novel nutraceutical compositions and use thereof |
| NO322041B1 (no) | 2004-10-22 | 2006-08-07 | Pharmalogica As | Naeringsmiddelsupplement inneholdende fiskeolje og melkefaststoff som emulgator og fremgangsmate for fremstilling. |
| US20060172012A1 (en) * | 2005-01-28 | 2006-08-03 | Finley John W | Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks |
| NO323665B1 (no) * | 2005-06-27 | 2007-06-18 | Pharmalogica As | Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling. |
| NO324262B1 (no) | 2005-11-29 | 2007-09-17 | Pharmalogica As | Bruksklar sammensetning omfattende fiskeolje og juice og fremstilling av denne, samt en forseglet beholder. |
| US20080058418A1 (en) * | 2006-09-06 | 2008-03-06 | The Coca-Cola Company | Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion |
| DE202007013532U1 (de) * | 2007-09-26 | 2007-12-13 | Orthomol Pharmazeutische Vertriebs Gmbh | Zusammensetzung enthaltende Phospholipide, geeignet zur Stärkung der Gehirn- und Gedächtnisfunktion |
| NO20081487L (no) | 2008-03-27 | 2009-09-28 | Smartfish As | Helsefremmende drikk |
| NO333013B1 (no) * | 2009-07-06 | 2013-02-18 | Smartfish As | Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning. |
| EP2279667A1 (en) * | 2009-07-30 | 2011-02-02 | Brudy Technology, S.L. | Vegetable and marine oil or fat compositions enriched with DHA or EPA and C18 or higher fatty acid |
| WO2012025229A1 (en) * | 2010-08-27 | 2012-03-01 | Persavita Ltd. | Composition and method of manufacture |
| ES2727043T3 (es) * | 2011-03-18 | 2019-10-11 | Nestle Sa | Composiciones y métodos útiles para mejorar enfermedades relacionadas con la edad |
| WO2014000264A1 (en) | 2012-06-29 | 2014-01-03 | Qualcomm Incorporated | Td-scdma rscp measurement correlation |
| JP6648007B2 (ja) * | 2013-06-13 | 2020-02-14 | スマートフィッシュ・アーエス | アルツハイマー病の治療、遅延及び/又は予防において使用するための、レスベラトロール又はその誘導体を含む水産油配合物 |
-
2014
- 2014-06-13 JP JP2016519474A patent/JP6648007B2/ja not_active Expired - Fee Related
- 2014-06-13 AU AU2014278839A patent/AU2014278839B2/en not_active Ceased
- 2014-06-13 SI SI201431224T patent/SI3016666T1/sl unknown
- 2014-06-13 WO PCT/NO2014/050099 patent/WO2014200356A1/en not_active Ceased
- 2014-06-13 ES ES14811285T patent/ES2732307T3/es active Active
- 2014-06-13 CA CA2914767A patent/CA2914767A1/en not_active Abandoned
- 2014-06-13 KR KR1020167000696A patent/KR20160018801A/ko not_active Ceased
- 2014-06-13 PL PL14811285T patent/PL3016666T3/pl unknown
- 2014-06-13 DK DK14811285.7T patent/DK3016666T3/da active
- 2014-06-13 MX MX2015016931A patent/MX363853B/es active IP Right Grant
- 2014-06-13 US US14/304,108 patent/US9717704B2/en active Active
- 2014-06-13 PT PT14811285T patent/PT3016666T/pt unknown
- 2014-06-13 CN CN201480033677.3A patent/CN105283190A/zh active Pending
- 2014-06-13 EP EP14811285.7A patent/EP3016666B1/en not_active Revoked
-
2019
- 2019-03-05 JP JP2019039948A patent/JP2019081807A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014278839A1 (en) | 2015-12-10 |
| ES2732307T3 (es) | 2019-11-21 |
| AU2014278839B2 (en) | 2019-06-20 |
| CA2914767A1 (en) | 2014-12-18 |
| HK1223263A1 (en) | 2017-07-28 |
| WO2014200356A1 (en) | 2014-12-18 |
| SI3016666T1 (sl) | 2019-09-30 |
| US20150031653A1 (en) | 2015-01-29 |
| EP3016666A1 (en) | 2016-05-11 |
| US9717704B2 (en) | 2017-08-01 |
| JP6648007B2 (ja) | 2020-02-14 |
| PL3016666T3 (pl) | 2019-09-30 |
| JP2016523857A (ja) | 2016-08-12 |
| JP2019081807A (ja) | 2019-05-30 |
| MX2015016931A (es) | 2016-04-04 |
| DK3016666T3 (da) | 2019-07-01 |
| EP3016666A4 (en) | 2017-03-15 |
| KR20160018801A (ko) | 2016-02-17 |
| EP3016666B1 (en) | 2019-05-15 |
| MX363853B (es) | 2019-04-05 |
| CN105283190A (zh) | 2016-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL241013A0 (en) | Prevention or inhibition of cold sore response in plants | |
| IL245101A0 (en) | Derivatives of 1,4-cyclohexylamine and processes for their preparation | |
| PT2986304T (pt) | Composição farmacêutica, métodos para o tratamento e suas utilizações | |
| IL238876A0 (en) | Indoleamine 2,3-dioxygenase inhibitors, preparations containing them and their uses | |
| PT3016666T (pt) | Formulação de óleo marinho que compreende resveratrol ou derivados do mesmo para utilizar no tratamento, retardamento e/ou prevenção de doença de alzheimer | |
| PT2968434T (pt) | Composições de c1-inh e para uso na prevenção e no tratamento de distúrbios associados a deficiência de inibidor da c1-esterase | |
| PT2945642T (pt) | Proteína do fator 1 para utilização no tratamento ou prevenção de doenças | |
| HUE046924T2 (hu) | Módszerek és készítmények Barth szindróma megelõzésében vagy kezelésében történõ alkalmazásra | |
| ZA201506968B (en) | Custom packaging center and packaging for use in the custom packaging center | |
| EP2981554A4 (en) | Methods and compositions for treating and preventing disease associated with avb8 integrin | |
| EP2976091C0 (de) | Antioxidativ wirksame zusammensetzung und deren verwendung | |
| IL244693A0 (en) | History of piperazine and their use as drugs | |
| ZA201706254B (en) | Oil blends, processes for the preparation thereof and their use in formulas | |
| EP3162377A4 (en) | Use of -asarone in preparing drugs for preventing and treating alzheimer's disease | |
| EP2980096A4 (en) | 2,3,5-trihydroxy-androst-6-one, as well as method of preparation and use thereof | |
| GB2510477B (en) | Formulations for use in the treatment of chronic fatigue and associated conditions, etc | |
| EP3048886A4 (en) | 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use | |
| SI3062636T1 (sl) | Uporaba rastlinskega ekstrakta za preprečevanje in zdravljenje izgube las | |
| EP2985276A4 (en) | Formulations based on nanoemulsions and the use thereof for treating obesity | |
| PL2931832T3 (pl) | Kompozycja do użytku fiducjarnego i dokument bezpieczeństwa, który ją wykorzystuje | |
| PT3177283T (pt) | Composto ativo e composição relacionada pata utilização dermatológica no campo farmacêutico ou cosmético | |
| IL237283A0 (en) | Dldh and its derivatives, and preparations containing them for medical use | |
| Rodriguez | Gut Bacteria May Exacerbate Depression | |
| AU2013101420A4 (en) | Novel ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injury | |
| ZA201600894B (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes |